LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio invited industrial biotech SMEs to learn about EU Policy Priorities

25/04/2021
NEWS RELEASE

EuropaBio invited industrial biotech SMEs to learn about EU Policy Priorities

Brussels, 26 April 2021 – EuropaBio organised an online info session for SMEs within industrial biotechnology to learn about the EU policies and their possible impact to their current business strategies. The event was organised as one of the initiatives under the EuropaBio SME Platform.

EuropaBio’s Industrial Biotechnology team Agnes Borg and Lucy McMurtry presented to participants an overview of relevant EU policies impacting industrial biotechnology under the European Green Deal including the Farm to Fork and Industrial strategies, Circular Economy Action Plan, and the Taxonomy Regulation. The participants had a chance to learn about opportunities within the Horizon Europe programme. Finally, the impacts of the recently adopted Transparency Regulation on the risk assessment process were explored.

The event was moderated by Claire Skentelbery, Director General of EuropaBio

Please click on the links to access the event’s slides and the recording.

The next online info session will take place June 3, 2021 and will be dedicated to EU Healthcare Biotech Policy Priorities for SMEs. Please register here.

About the EuropaBio SME Platform

The SME platform is a community of SMEs across all sectors in Europe, supported through regular online meetings around EU-level topics that impact commercial biotechnology and represented to EU stakeholders.

Download
SMEs-event_industrial-policies_sp_finalDownload

Share
Alexandra Simionca
Alexandra Simionca

Related posts

11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more

Important links

  • Industrial Decarbonisation Accelerator Act – EuropaBio Position
  • EuropaBio Position on the Critical Medicines Act

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.